|
Press Releases |
|
|
|
Tuesday, June 25, 2024 |
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China |
On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China. more info >> |
|
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China |
On June 25, China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the "Product") in atopic dermatitis ("AD") in China. more info >> |
|
Tuesday, June 18, 2024 |
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China |
more info >> |
|
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China |
more info >> |
|
Tuesday, April 23, 2024 |
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China |
more info >> |
|
China Medical System: New Drug Application of Desidustat Tablets Accepted in China |
China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 April 2024, the New Drug Application (NDA) of Desidustat Tablets ("Desidustat Tablets" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
Monday, April 1, 2024 |
|
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia |
more info >> |
|
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia |
more info >> |
|
Thursday, March 28, 2024 |
|
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs |
more info >> |
|
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs |
more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Mitsubishi Corporation and ExxonMobil sign Project Framework Agreement to advance world's largest low-carbon hydrogen project
Sept 13, 2024 20:07 JST
|
|
|
CBL International Limited發佈2024年中期業績
Sept 13, 2024 19:00 HKT/SGT
|
|
|
41st Watch & Clock Design Competition winners recognised at awards ceremony
Sept 13, 2024 18:45: JST
|
|
|
君聖泰醫藥亮相香港國際生物科技論壇
Sept 13, 2024 18:37 HKT/SGT
|
|
|
君圣泰医药亮相香港国际生物科技论坛
Sept 13, 2024 18:22 HKT/SGT
|
|
|
Taiwan Excellence Pavilion concludes Medical Fair Asia 2024 with Showcase of Cutting-Edge MedTech Innovations
Sept 13, 2024 17:50 HKT/SGT
|
|
|
41st Watch & Clock Design Competition winners recognised at awards ceremony
Sept 13, 2024 17:45 HKT/SGT
|
|
|
MFJ All Japan Trial Championship: Team HRC Competes with RTL ELECTRIC Trial Bike
Sept 13, 2024 17:22 JST
|
|
|
The Sukhothai Spa at The Sukhothai Bangkok Unveils a Tranquil Oasis in the Heart of the City
Sept 13, 2024 16:00: JST
|
|
|
The Sukhothai Spa at The Sukhothai Bangkok Unveils a Tranquil Oasis in the Heart of the City
Sept 13, 2024 15:00 HKT/SGT
|
|
|
Subsea Communications Leaders Come Together For The Annual Global Coverage Gathering At Submarine Networks World In Singapore
Sept 13, 2024 14:46 HKT/SGT
|
|
|
9th Belt and Road Summit draws to a successful close
Sept 13, 2024 09:50: JST
|
|
|
NEC uses AI to analyze the trustworthiness of information and support fact-checking
Sept 13, 2024 10:18 JST
|
|
|
DENSO to Transfer All Its NiPPA Shares to Nippon Mirai Capital
Sept 13, 2024 9:59 JST
|
|
|
9th Belt and Road Summit draws to a successful close
Sept 13, 2024 08:50 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|